Steven Margossian

2.7k total citations
32 papers, 922 citations indexed

About

Steven Margossian is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Steven Margossian has authored 32 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Steven Margossian's work include CAR-T cell therapy research (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Steven Margossian is often cited by papers focused on CAR-T cell therapy research (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Steven Margossian collaborates with scholars based in United States, Spain and India. Steven Margossian's co-authors include Ronald A. Butow, Alan D. D’Andrea, Toshiyasu Taniguchi, Hans Peter Zassenhaus, Huilin Li, David Landsman, Piotr P. Stępień, Gary P. H. Ho, Christopher A. Walsh and Raksha Mudbhary and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Steven Margossian

30 papers receiving 914 citations

Peers

Countries citing papers authored by Steven Margossian

Since Specialization

Citations

This map shows the geographic impact of Steven Margossian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Margossian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Margossian more than expected).

Fields of papers citing papers by Steven Margossian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Margossian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Margossian. The network helps show where Steven Margossian may publish in the future.

Co-authorship network of co-authors of Steven Margossian

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Margossian. A scholar is included among the top collaborators of Steven Margossian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Margossian. Steven Margossian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC). 2024 ·Journal of Clinical Oncology ·A. Dimitrios Colevas, Christine H. Chung, Douglas R. Adkins, Cristina P. Rodriguez, Jong Chul Park, Michael K. Gibson, Ammar Sukari, Francis P. Worden, Faye M. Johnson, Nabil F. Saba, Barbara Burtness, Ricklie Julian, Julie E. Bauman, Robert M. Jotte, Tanguy Y. Seiwert, Lara Dunn, Marya Chaney, Steven Margossian, Matteo Levisetti, Sara I. Pai	8
2	Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients 2022 ·Transplantation and Cellular Therapy ·Kevin X. Liu, (unknown), (unknown), Nicholas Moore, Yu‐Hui Chen, Steven Margossian, Jennifer Whangbo, Christine Duncan, Leslie Lehmann, Karen J. Marcus	2
3	A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer. 2022 ·Journal of Clinical Oncology ·Christine H. Chung, A. Dimitrios Colevas, Douglas R. Adkins, Michael K. Gibson, Cristina P. Rodriguez, Ammar Sukari, Julie E. Bauman, Lori J. Wirth, Faye M. Johnson, Nabil F. Saba, Barbara Burtness, Lara Dunn, Tanguy Y. Seiwert, Francis P. Worden, Jameel Muzaffar, Steven Margossian, Raymond J. Moniz, Steven N. Quayle, Matteo Levisetti, Sara I. Pai	9
4	Low Rates of Venoocclusive Disease and Non-Relapse Mortality in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Following Inotuzumab Ozogamicin Reinduction for Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia 2021 ·Blood ·(unknown), (unknown), Andrew E. Place, Christine Duncan, Steven Margossian, Leslie Lehmann, John Horan, Malika Kapadia, Jennifer Whangbo, (unknown), Melissa Burns, Leslie S. Kean, Lewis B. Silverman, Donna Neuberg, Susanne H.C. Baumeister	0
5	Real-World Outcomes for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (ALL) Treated with Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry 2021 ·Blood ·Samuel John, Michael A. Pulsipher, Amy Moskop, Zhen‐Huan Hu, Christine L. Phillips, (unknown), Steven Margossian, Sarah Nikiforow, Paul L. Martin, Benjamin Oshrine, Amy K. Keating, Rayne H. Rouce, Ranjan Tiwari, Santiago Redondo, Jennifer Willert, (unknown), Marcelo C. Pasquini, Stephan A. Grupp	12
6	Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia 2021 ·Transplantation and Cellular Therapy ·(unknown), Kavitha Ramaswamy, Jessica Flynn, Audrey Mauguen, Karlo Perica, Jae H. Park, Christopher J. Forlenza, Neerav Shukla, Peter G. Steinherz, Steven Margossian, Jaap Jan Boelens, Nancy A. Kernan, Kevin J. Curran	28
7	Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant 2020 ·Bone Marrow Transplantation ·Vanessa A. Fabrizio, Nancy A. Kernan, Farid Boulad, Maria Cancio, Jennifer D. Allen, Meghan A. Higman, Steven Margossian, Audrey Mauguen, Susan E. Prockop, Andromachi Scaradavou, Niketa C. Shah, Barbara Spitzer, Elliot Stieglitz, Nicholas D. Yeager, Richard J. O’Reilly, Renier J. Brentjens, Jaap Jan Boelens, Kevin J. Curran	15
8	Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children 2018 ·Blood ·Michelle Long Schoettler, Meera Subramaniam, Steven Margossian	3
9	Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation 2017 ·Pediatric Blood & Cancer ·(unknown), Hisham Dahmoush, Frederick D. Grant, Leslie Lehmann, Ann S. LaCasce, Amy L. Billett, Steven Margossian	2
10	High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL 2017 ·Blood ·Kevin J. Curran, Steven Margossian, Nancy A. Kernan, Lewis B. Silverman, Jae H. Park, Craig S. Sauter, Eric L. Smith, Farid Boulad, Maria Cancio, Christopher J. Forlenza, Carolyn C. Jackson, Neerav Shukla, Barbara Spitzer, Susan E. Prockop, Peter G. Steinherz, Andrew L. Kung, Richard J. O’Reilly, Isabelle Rivière, Michel Sadelain, Renier J. Brentjens	1
11	A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell Transplantation 2016 ·Photomedicine and Laser Surgery ·Nathaniel S. Treister, Wendy B. London, Dongjing Guo, Maggie Malsch, (unknown), (unknown), Steven Margossian, Christine Duncan	26
12	Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center 2016 ·Biology of Blood and Marrow Transplantation ·R. Grant Rowe, Dongjing Guo, Michelle Lee, Steven Margossian, Wendy B. London, Leslie Lehmann	24
13	Pediatric hematopoietic cell transplantation 2015 ·Journal of Pediatric Intensive Care ·Kathryn Walsh, Steven Margossian, Christine Duncan	1
14	Impact of needleless connector change frequency on central line-associated bloodstream infection rate 2014 ·American Journal of Infection Control ·Thomas J. Sandora, Dionne A. Graham, (unknown), Brenda Dodson, Gail Potter-Bynoe, Steven Margossian	3
15	Nonmelanoma Skin Cancer in Childhood After Hematopoietic Stem Cell Transplant 2013 ·Journal of Pediatric Hematology/Oncology ·Jillian F. Rork, Steven Margossian, Vinod E. Nambudiri, Jennifer T. Huang	12
16	763 2012 ·Critical Care Medicine ·Jennifer McArthur, Julie C. Fitzgerald, Rajinder Bajwa, Steven Margossian, Andrew J. Yates, Christine Duncan, Julie‐An Talano, Debra Spear, (unknown), Robert F. Tamburro	0
17	Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors 2010 ·Journal of Cell Science ·Sofia B. Lizarraga, Steven Margossian, Marian H. Harris, Dean R. Campagna, Anping Han, (unknown), Raksha Mudbhary, Jane E. Barker, Christopher A. Walsh, Mark D. Fleming	7
18	Direct DNA Binding Activity of the Fanconi Anemia D2 Protein 2005 ·Journal of Biological Chemistry ·Grace Park, Steven Margossian, Andrew A. Horwitz, (unknown), Alan D. D’Andrea, Jeffrey D. Parvin	62
19	Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A 2003 ·Intensive Care Medicine ·Ravi R. Thiagarajan, Stephen J. Roth, Steven Margossian, Andrew S. Mackie, Ellis J. Neufeld, Peter C. Laussen, Joseph M. Forbess, Elizabeth D. Blume	7
20	The DExH Box Protein Suv3p Is a Component of a Yeast Mitochondrial 3′-to-5′ Exoribonuclease That Suppresses Group I Intron Toxicity 1996 ·Cell ·Steven Margossian, Huilin Li, Hans Peter Zassenhaus, Ronald A. Butow	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact